Contact
searchSearch
HMP Global

News

News
Subpotent Diarrhea Drug Recalled
11/09/2023
Edenbridge Pharmaceuticals is recalling 4548 bottles of opium tincture for subpotency, according to the November 8, 2023, US Food and Drug Administration (FDA) Enforcement Report.
Edenbridge Pharmaceuticals is recalling 4548 bottles of opium tincture for subpotency, according to the November 8, 2023, US Food and Drug Administration (FDA) Enforcement Report.
Edenbridge Pharmaceuticals is...
11/09/2023
Pharmacy Learning Network
News
Iodine Solution Recalled
11/09/2023
Safecor Health is recalling 166,022 bottles of strong iodine solution because of Current Good Manufacturing Practice deviations. The November 8, 2023, US Food and Drug Administration (FDA) Enforcement Report cites the absence of compendial...
Safecor Health is recalling 166,022 bottles of strong iodine solution because of Current Good Manufacturing Practice deviations. The November 8, 2023, US Food and Drug Administration (FDA) Enforcement Report cites the absence of compendial...
Safecor Health is recalling...
11/09/2023
Pharmacy Learning Network
News
EPA Testing Confirms DIY Air Filters Are Highly Effective in Trapping Viruses
11/09/2023
EPA testing reveals that DIY air filters known as Corsi-Rosenthal boxes are 99% effective in trapping airborne viruses, providing a low-cost way to protect against respiratory diseases like flu, RSV, and COVID-19.
EPA testing reveals that DIY air filters known as Corsi-Rosenthal boxes are 99% effective in trapping airborne viruses, providing a low-cost way to protect against respiratory diseases like flu, RSV, and COVID-19.
EPA testing reveals that DIY air...
11/09/2023
Pharmacy Learning Network
News
Antifungal Cream Recalled
11/08/2023
The recall affects Gynazole-1 (butoconazole nitrate) vaginal cream, 2%, 1 prefilled applicator per carton (NDC 45802-396-01), from lot 164185 (Exp. 4/24). The product was manufactured by Padagis, Yeruham, Israel, and distributed by Padagis,...
The recall affects Gynazole-1 (butoconazole nitrate) vaginal cream, 2%, 1 prefilled applicator per carton (NDC 45802-396-01), from lot 164185 (Exp. 4/24). The product was manufactured by Padagis, Yeruham, Israel, and distributed by Padagis,...
The recall affects Gynazole-1...
11/08/2023
Pharmacy Learning Network
News
Cost-Effectiveness of Lisocabtagene Maraleucel vs Axicabtagene Ciloleucel and Tisagenlecleucel for Third-Line or Later Treatment for R/R DLBCL
11/06/2023
Researchers compared the cost of treatment for different chimeric antigen receptor T-cell therapies as third-line or later treatment for patients with relapsed or refractory large B-cell lymphoma in the US.
Researchers compared the cost of treatment for different chimeric antigen receptor T-cell therapies as third-line or later treatment for patients with relapsed or refractory large B-cell lymphoma in the US.
Researchers compared the cost of...
11/06/2023
Pharmacy Learning Network
News
VNS Added to Antiseizure Medication Appears Cost Effective for Drug-Resistant Epilepsy
11/06/2023
Researchers suggest that vagus nerve stimulation (VNS) may decrease the frequency of seizures, potentially enhancing patient well-being and reducing health care expenses for Medicare. However, they acknowledge the need for additional data to...
Researchers suggest that vagus nerve stimulation (VNS) may decrease the frequency of seizures, potentially enhancing patient well-being and reducing health care expenses for Medicare. However, they acknowledge the need for additional data to...
Researchers suggest that vagus...
11/06/2023
Pharmacy Learning Network
News
CDC Report: Emphasize Counterfeit Pill Risks in Overdose Prevention Messaging
11/06/2023
The number of overdose deaths caused by counterfeit pills has more than doubled from July 2019 to September 2019 to October 2021 to December 2021. It has tripled in western US states, with the majority of those who used counterfeit pills...
The number of overdose deaths caused by counterfeit pills has more than doubled from July 2019 to September 2019 to October 2021 to December 2021. It has tripled in western US states, with the majority of those who used counterfeit pills...
The number of overdose deaths...
11/06/2023
Pharmacy Learning Network
News
FDA Approves Dostarlimab-gxly With Chemotherapy for Patients With Endometrial Cancer
11/05/2023
In July 2023, the FDA approved dostarlimab-gxly with carboplatin and paclitaxel for the treatment of advanced endometrial cancer in adult patients.
In July 2023, the FDA approved dostarlimab-gxly with carboplatin and paclitaxel for the treatment of advanced endometrial cancer in adult patients.
In July 2023, the FDA approved...
11/05/2023
Pharmacy Learning Network
News
How a Therapeutic Reference Pricing Approach Could Benefit Medicare's Drug Price Negotiations
11/03/2023
This study explores how Medicare could save billions of dollars by using a therapeutic reference pricing approach that considers comparative effectiveness and the costs of therapeutic alternatives for negotiating drug prices.
This study explores how Medicare could save billions of dollars by using a therapeutic reference pricing approach that considers comparative effectiveness and the costs of therapeutic alternatives for negotiating drug prices.
This study explores how Medicare...
11/03/2023
Pharmacy Learning Network
News
Optimizing Treatment Choices for Venous Thromboembolism: A Cost-Effectiveness Analysis of Direct Oral Anticoagulants
11/03/2023
Investigating the economic considerations of using direct oral anticoagulants (DOACs) compared to low-molecular-weight heparin (LMWH) in the treatment of venous thromboembolism, this research reveals the nuanced cost-effectiveness dynamics,...
Investigating the economic considerations of using direct oral anticoagulants (DOACs) compared to low-molecular-weight heparin (LMWH) in the treatment of venous thromboembolism, this research reveals the nuanced cost-effectiveness dynamics,...
Investigating the economic...
11/03/2023
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use